PTC Therapeutics, Inc. Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock
PTC Therapeutics, Inc. (PTCT) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock of 13.88 thousand shares for the 12-month period ending 2012-12-31, per its 10-K filed 2015-03-02.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock · last filed 2015-03-02
- PTC Therapeutics, Inc. incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2012-06-30 was 7.66K shares.
- PTC Therapeutics, Inc. incremental common shares attributable to dilutive effect of conversion of preferred stock for fiscal 2012 was 13.88K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 3 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 6 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 9 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 12 month |
|---|---|---|---|---|
| 2012-12-31 | 13.88K shares 10-K · filed 2015-03-02 | |||
| 2012-09-30 | 10.66K shares 10-Q · filed 2013-11-14 | |||
| 2012-06-30 | 7.66K shares 10-Q · filed 2013-08-13 | 3.83K shares 10-Q · filed 2013-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |